No Survival Benefit Associated with Waiting for Non-Lung Donor Heart Transplants for Recipients with Adult Congenital Heart Disease
Michael J. Diamant(Royal Columbian Hospital), Jonathan N. Menachem(Vanderbilt University Medical Center), Arieh Fox(Mount Sinai Hospital), Kelly Schlendorf(Vanderbilt University Medical Center), Benjamin P. Frischhertz(Vanderbilt University Medical Center), Ari Cedars(Providence Sacred Heart Medical Center), Vivek Modi(St. Luke's University Health Network), Jeremy A. Mazurek(University of Pennsylvania), Ashish S. Shah(Vanderbilt University Medical Center), Sandip Zalawadiya(Vanderbilt University Medical Center), Daniel E. Clark(Stanford University), Anjali Joshi(Merck & Co., Inc., Rahway, NJ, USA (United States)), David P. Bichell(Vanderbilt University), R. Fowler(Vanderbilt University Medical Center), JoAnn Lindenfeld(Brigham and Women's Hospital)
Cited by 0
Related Papers
Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound
|Journal of the American College of Cardiology|2002|1k
Genetic Evaluation of Cardiomyopathy—A Heart Failure Society of America Practice Guideline
|Journal of Cardiac Failure|2009|705
Clinical Risk Factors for Primary Graft Dysfunction after Lung Transplantation
|American Journal of Respiratory and Critical Care Medicine|2013|686
Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction
|Circulation|2019|427
Transplantation Outcomes with Donor Hearts after Circulatory Death
|New England Journal of Medicine|2023|328